title: Evidence-based guideline: IV immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
authors.forename: Hai-feng
authors.initials: HF
authors.lastname: Li
authors.forename: Xiang
authors.initials: X
authors.lastname: Gao
authors.forename: Yu
authors.initials: Y
authors.lastname: Hong
authors.forename: Huned S
authors.initials: HS
authors.lastname: Patwa
authors.forename: Vinay
authors.initials: V
authors.lastname: Chaudhry
authors.forename: Alex D
authors.initials: AD
authors.lastname: Rae-Grant
authors.forename: Yuen T
authors.initials: YT
authors.lastname: So
authors.forename: Palo
authors.initials: P
authors.lastname: Alto
mesh_terms: D019317:Evidence-Based Medicine / Q000592:standards*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D009462:Neurology / Q000592:standards*; D009468:Neuromuscular Diseases / Q000188:drug therapy*; D013673:Technology Assessment, Biomedical / Q000592:standards*
chemical_list: D016756:Immunoglobulins, Intravenous